Epigenetic Biomarkers of Transition from Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Phenotype: A Prospective Study
Authors:
- Carolina Gutiérrez-RepisoCGCarolina Gutiérrez-Repiso
- Teresa María Linares-PinedaTLTeresa María Linares-Pineda
- Andres Gonzalez-JimenezAGAndres Gonzalez-Jimenez
- Francisca Aguilar-LinerosFAFrancisca Aguilar-Lineros
- Sergio ValdésSVSergio Valdés
- Federico SoriguerFSFederico Soriguer
- Gemma Rojo-MartínezGemma Rojo-Martínez
- Francisco J. TinahonesFTFrancisco J. Tinahones
- Sonsoles MorcilloSMSonsoles Morcillo
Open Access
- 27 September 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10417
Abstract
Background: Identifying those parameters that could potentially predict the deterioration of metabolically healthy phenotype is a matter of debate. In this field, epigenetics, in particular DNA methylation deserves special attention. Results: The aim of the present study was to analyze the long-term evolution of methylation patterns in a subset of metabolically healthy subjects in order to search for epigenetic markers that could predict the progression to an unhealthy state. Twenty-six CpG sites were significantly differentially methylated, both at baseline and 11-year follow-up. These sites were related to 19 genes or pseudogenes; a more in-depth analysis of the methylation sites of these genes showed that CYP2E1 had 50% of the collected CpG sites differently methylated between stable metabolically healthy obesity (MHO) and unstable MHO, followed by HLA-DRB1 (33%), ZBTB45 (16%), HOOK3 (14%), PLCZ1 (14%), SLC1A1 (12%), MUC2 (12%), ZFPM2 (12.5%) and HLA-DQB2 (8%). Pathway analysis of the selected 26 CpG sites showed enrichment in pathways linked to th1 and th2 activation, antigen presentation, allograft rejection signals and metabolic processes. Higher methylation levels in the cg20707527 (ZFPM2) could have a protective effect against the progression to unstable MHO (OR: 0.21, 95%CI (0.067–0.667), p < 0.0001), whilst higher methylation levels in cg11445109 (CYP2E1) would increase the progression to MUO; OR: 2.72, 95%CI (1.094–6.796), p < 0.0014; respectively). Conclusions: DNA methylation status is associated with the stability/worsening of MHO phenotype. Two potential biomarkers of the transition to an unhealthy state were identified and deserve further investigation (cg20707527 and cg11445109). Moreover, the described differences in methylation could alter immune system-related pathways, highlighting these pathways as therapeutic targets to prevent metabolic deterioration in MHO patients.Keywords
Funding Information
- Instituto de Salud Carlos III (FI19/00178 ; CP20/00066; PI15-01350)
- Consejería de Salud y Familias, Junta de Andalucía (C-0050-2017)
This publication has 44 references indexed in Scilit:
- A genome-wide methylation study on obesityEpigenetics, 2013
- Low-level processing of Illumina Infinium DNA Methylation BeadArraysNucleic Acids Research, 2013
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation dataBioinformatics, 2012
- Factors determining weight gain in adults and relation with glucose toleranceClinical Endocrinology, 2012
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- Integrating Pathway Analysis and Genetics of Gene Expression for Genome-wide Association StudiesThe American Journal of Human Genetics, 2010
- Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?Diabetes Care, 2009
- Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heartJournal of Clinical Investigation, 2009
- CYP2E1 and oxidative liver injury by alcoholFree Radical Biology and Medicine, 2008
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001